MDxHealth (MDXH) Registration Filing summary

Management team and governance

• CEO and principal executive officer is Michael McGarrity, who also serves as attorney-in-fact.

• CFO and principal financial and accounting officer is Ron Kalfus.

• Board includes Koen Hoffman (Chairman), Dr. Lieve Verplancke, Hilde Windels, Dr. Regine Slagmulder, Dr. Eric Bednarski, and Donnie M. Hardison.

• Directors and officers are covered by liability insurance and contractual indemnification agreements, subject to Belgian law limitations.

Offering details and pricing

• Securities may be offered on a delayed or continuous basis under Rule 415.

• Registration statement may be amended to reflect changes in offering volume or price within a 20% range.

• Unsold securities may be removed from registration by post-effective amendment.

Risk factors and disclosures

• Directors may be liable for damages under Belgian law for improper performance or legal infringements.

• Indemnification for liabilities under the Securities Act may be unenforceable as contrary to public policy.

• Indemnification agreements may discourage shareholder litigation against directors and officers.